Emerg Infect Dis. 2022 Jan;28(1):29-34. doi: 10.3201/eid2801.211543.
Rare fungal pathogens are emerging as agents of invasive fungal infections. We analyzed 13 cases of fungal infections caused by Kazachstania (Arxiozyma) spp. in Strasbourg University Hospital, Strasbourg, France. Among the cases, 4 patients had proven fungal disease (3 cases of invasive fungal disease and 1 mucocutaneous infection) and 9 were colonized by Kazachstania (Arxiozyma) spp. Candida albicans was also isolated from 11 of the 13 patients. None of the patients with proven invasive fungal disease met host criteria, but most had underlying diseases. All strains were identified as K. telluris by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and 3 were confirmed as K. bovina by internal transcribed spacer sequencing. For all tested strains, the MICs for fluconazole were >2 μg/mL. Emergence of this rare fungal infection might be explained by the increasing number of patients with immunocompromised conditions and gastroesophageal diseases.
罕见的真菌病原体正在成为侵袭性真菌感染的病原体。我们分析了法国斯特拉斯堡大学医院 13 例由 Kazachstania(Arxiozyma)引起的真菌感染病例。在这些病例中,4 例患者患有确诊的真菌感染(3 例侵袭性真菌感染和 1 例黏膜皮肤感染),9 例患者被 Kazachstania(Arxiozyma)定植。13 例患者中有 11 例分离出白色念珠菌。所有患有确诊侵袭性真菌感染的患者均不符合宿主标准,但大多数患者均患有基础疾病。基质辅助激光解吸/电离飞行时间质谱法将所有菌株鉴定为 K. telluris,内部转录间隔区测序证实 3 株为 K. bovina。所有测试菌株的氟康唑 MIC 值均>2μg/ml。这种罕见真菌感染的出现可能与免疫功能低下和胃食管疾病患者数量的增加有关。